Crowdr.tv

Portfolio news - November / December 2016

Several exciting updates from the last few weeks.

Proterra leads the way, with coverage in Forbes - and with press on three recent deals: (1) 15 new buses funded by the San Joaquin Valley Air Pollution Control District; (2) in the Chicago Tribune of an announcement in late October about a partnership with JLL to deliver 10 Catalyst buses for a service operating between Chicago’s commuter train stations the Prudential Plaza and Aon Center, both JLL-managed properties, in Chicago; and (3) the Pioneer Valley Transit Authority in Massachusetts.

Target Pharma continues to outperform, announcing its fourth disease community in partnership with Bristol-Myers Squibb - following its earlier announcement in partnership with Intercept Pharmaceuticals.

KIYATEC is not far behind - moving by popular acclaim from a startup to a breakout success. Keep up the good work.

Pharmright is accelerating nationally - demo'ing the Livi from Missouri to Maine.

Avadim announced its recognition by Vizient for the innovation of its technology and its plans to make $3.1 million of products per week at its new facility.

And lastly Crowdr provided a sneak peak of its mobile app Booster that launches in January. See you on there!

Portfolio news - August 2016

Many people may have been at the beach in South Carolina in August, but the VentureSouth portfolio companies continued to make waves.

First some product launches:

Servosity: Released its new generation disaster recovery platform

Pharmright: Reached a key milestone with the successful registration of Livi with the FDA. This should pave the way for sales in the fall, and will help start making prescription drug regimens easier to follow.

Baebies: Exhibited its novel FINDER platform at the AACC Annual Scientific Meeting and Clinical Lab Expo.

And secondly some well-deserved recognition:

We're proud to have not one, but two, portfolio companies nominated for 2016's Innovision Awards! - Atlas Organics and Crowdr TV. Impressive competition, but these are high caliber entries.

Avadim: named to the Inc 500's list of fastest growing companies: #234, with three-year sales growth of 1,675%!

VentureSouth's latest investments - Crowdr and Target

VentureSouth is pleased to announce its latest investments. Thanks to the Moultrie News, Charleston RBJ, and others for helping to publicize the exciting news for Crowdr and Target Pharma.

For the record, VentureSouth didn't invest the $637,000 listed on Crunchbase, Target doesn't have $1.4 million left to raise, and the Palmetto Angel Fund didn't invest all the $250,000 in Crowdr. Crunchbase is good, but initial SEC Form D filings and crowd-sourced data do not always tell the full story on fundraising!

Still, these were material investments for VentureSouth, and we're delighted to be partnering with such impressive companies. We wish both the best of luck.

And a self-plug: learn more about angel investing in SC at one of our upcoming sessions on Crowdr.